ISAC's Living Legends in Infectious Diseases

Living Legends in Infectious Diseases is a new podcast series from the International Society of Antimicrobial Chemotherapy (ISAC) celebrating the individuals whose work has shaped modern infectious diseases, antimicrobial stewardship, diagnostics and infection prevention & control.

Each episode offers a window into the challenges, motivations and defining moments that shaped these leaders’ journeys—and continue to shape the future of global health.

----------------------

About ISAC

Founded in 1961, the International Society of Antimicrobial Chemotherapy (ISAC) is a federation of Member Societies that aims to increase the knowledge of antimicrobial chemotherapy and combat antibiotic resistance around the world.

Every second year, ISAC organises the International Congress of Chemotherapy (ICC) – join ISAC in Manila in December 2026 for the 34th ICC.

ISAC hosts the ISAC Academy, an online education hub which features resources from ISAC, its Member Societies and other like-minded organisations.

ISAC has two international journals, the International Journal of Antimicrobial Agents (IJAA) and the Journal of Antimicrobial Chemotherapy (JGAR).

Links in the show notes.

Host

Ian Gould

Professor Ian Gould is a recently retired Consultant Microbiologist at the University of Aberdeen.

He has advised the Scottish and UK governments, the WHO, the European Commission and other international bodies, and coordinated the EU AMR projects ESAR and ARPAC. He helped establish Scotland’s AMR and antimicrobial stewardship (AMS) programmes.

A former President of the International Society of Antimicrobial Chemotherapy (ISAC) and the Scottish Microbiology Association, he has published over 400 papers, edited four books, and co‑founded the Journal of Global Antimicrobial Resistance. His career includes major contributions to AMS working groups, long‑standing collaborations in Slovakia, and honorary academic appointments. In 2025, ScholarGPS ranked him sixth worldwide for lifetime achievement in AMS research and nineteenth for antibiotic research.